These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 3904613)
21. Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis. Liu XP; Fan SR; Bai FY; Li J; Liao QP Mycoses; 2009 Jan; 52(1):24-8. PubMed ID: 18498300 [TBL] [Abstract][Full Text] [Related]
22. Integrated antifungal drug discovery in Candida albicans. Sanglard D Nat Biotechnol; 2001 Mar; 19(3):212-3. PubMed ID: 11231545 [No Abstract] [Full Text] [Related]
23. Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis. Navarathna DH; Hornby JM; Hoerrmann N; Parkhurst AM; Duhamel GE; Nickerson KW J Antimicrob Chemother; 2005 Dec; 56(6):1156-9. PubMed ID: 16239285 [TBL] [Abstract][Full Text] [Related]
24. Characterization of Hwp2, a Candida albicans putative GPI-anchored cell wall protein necessary for invasive growth. Hayek P; Dib L; Yazbeck P; Beyrouthy B; Khalaf RA Microbiol Res; 2010 Mar; 165(3):250-8. PubMed ID: 19616419 [TBL] [Abstract][Full Text] [Related]
25. Advances in molecular genetics of Candida albicans and Candida glabrata. Brown AJ; Cormack BP; Gow NA; Kvaal C; Soll DR; Srikantha T Med Mycol; 1998; 36 Suppl 1():230-7. PubMed ID: 9988512 [TBL] [Abstract][Full Text] [Related]
26. Molecular organization of the cell wall of Candida albicans and its relation to pathogenicity. Ruiz-Herrera J; Elorza MV; ValentÃn E; Sentandreu R FEMS Yeast Res; 2006 Jan; 6(1):14-29. PubMed ID: 16423067 [TBL] [Abstract][Full Text] [Related]
28. Morphogenesis in Candida albicans. Odds FC Crit Rev Microbiol; 1985; 12(1):45-93. PubMed ID: 3893894 [TBL] [Abstract][Full Text] [Related]
29. The biology of mating in Candida albicans. Johnson A Nat Rev Microbiol; 2003 Nov; 1(2):106-16. PubMed ID: 15035040 [TBL] [Abstract][Full Text] [Related]
30. Effects of IgY against Candida albicans and Candida spp. Adherence and Biofilm Formation. Fujibayashi T; Nakamura M; Tominaga A; Satoh N; Kawarai T; Narisawa N; Shinozuka O; Watanabe H; Yamazaki T; Senpuku H Jpn J Infect Dis; 2009 Sep; 62(5):337-42. PubMed ID: 19762981 [TBL] [Abstract][Full Text] [Related]
31. Anti-Candida property of a lignan glycoside derived from Styrax japonica S. et Z. via membrane-active mechanisms. Park C; Woo ER; Lee DG Mol Cells; 2010 Jun; 29(6):581-4. PubMed ID: 20496119 [TBL] [Abstract][Full Text] [Related]
32. Pathogenicity of Candida albicans with particular reference to the vagina. Ryley JF J Med Vet Mycol; 1986 Feb; 24(1):5-22. PubMed ID: 3517278 [No Abstract] [Full Text] [Related]
34. Conservation of genetic linkage in nonisogenic isolates of Candida albicans. Poulter R; Hanrahan V J Bacteriol; 1983 Nov; 156(2):498-506. PubMed ID: 6355060 [TBL] [Abstract][Full Text] [Related]
35. Recombinogenic activity of nalidixic acid for artificial hybrids but not for natural strains of Candida albicans: evidence for the monoploidy of natural strains. Sarachek A Z Allg Mikrobiol; 1983; 23(6):385-91. PubMed ID: 6356639 [TBL] [Abstract][Full Text] [Related]